The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated

Gastrointestinal Endoscopy

Volumn 59, Issue 7, 2004, Pages 788-794

  Boonpongmanee, Somprak ^b   Fleischer, David E ^a   Pezzullo, John C ^b   Collier, Kevin ^b   Mayoral, William ^b   Al Kawas, Firas ^b   Chutkan, Robynne ^b   Lewis, James H ^b   Tio, Thian L ^b   Benjamin, Stanley B ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; EVALUATION; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNIVERSITY; UPPER GASTROINTESTINAL BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MALLORY-WEISS SYNDROME; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; UNITED STATES;

EID: 3042709617     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(04)00181-6     Document Type: Article

References (24)

1. Gilbert D.A. Epidemiology of upper gastrointestinal bleeding. Gastrointest Endosc. 36:(Suppl 5):1990;S8-S13
2. Silverstein F.E., Gilbert D.A., Tedesco F.J., Buenger N.K., Persing J. The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc. 27:1981;80-93
3. Laine L., Peterson W.L. Bleeding peptic ulcer. N Engl J Med. 331:1994;717-727
4. Longstreth G.F. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol. 90:1995;206-210
5. Yavorski R.T., Wong R.K., Maydonovitch C., Battin L.S., Furnia A., Amundson D.E. Analysis of 3, 294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol. 90:1995;568-573
6. Fleiss J.L. Statistical methods for rates and proportions. 2nd ed. 1981;Wiley and Sons, New York
7. Wara P. Endoscopic prediction of major rebleeding: a prospective study of stigmata of hemorrhage in bleeding ulcer. Gastroenterology. 88:1985;1209-1214
8. Swain C.P., Storey D.W., Bown S.G., Heath J., Mills T.N., Salmon P.R., et al. Nature of the bleeding vessel in recurrently bleeding gastric ulcers. Gastroenterology. 90:1986;595-608
9. Peura D.A., Lanza F.L., Gostout C.J., Foutch P.G. The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol. 92:1997;924-928
10. Rockall T.A., Logan R.F., Devlin H.B., Northfield T.C. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ. 311:1995;222-226
11. Vreeburg E.M., Snel P., de Bruijne J.W., Bartelsman J.F., Rauws E.A., Tytgat G.N. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol. 92:1997;236-243
12. Blatchford O., Davidson L.A., Murray W.R., Blatchford M., Pell J. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ. 315:1997;510-514
13. Czernichow P., Hochain P., Nousbaum J.B., Raymond J.M., Rudelli A., Dupas J.L., et al. Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol. 12:2000;175-181
14. Munnangi S., Sonnenberg A. Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States. Arch Intern Med. 157:1997;1489-1494
15. el-Serag H.B., Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 43:1998;327-333
16. Belaiche J., Burette A., De Vos M., Louis E., Huybrechts M., Deltenre M. Belgian Study Group of NSAID-GI Complications. Observational survey of NSAID-related upper gastro-intestinal adverse events in Belgium. Acta Gastroenterol Belg. 65:2002;65-73
17. Ofman J.J., MacLean C.H., Straus W.L., Morton S.C., Berger M.L., Roth E.A., et al. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol. 29:2002;804-812
18. Garner S., Fidan D., Frankish R., Judd M., Towheed T., Wells G., et al. Rofecoxib for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev. (3):2002;CD003685
19. Laine L. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum. 32:(3 Suppl 1):2002;25-32
20. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther. 9:(Suppl 2):1995;45-51
21. Banatvala N., Mayo K., Megraud F., Jennings R., Deeks J.J., Feldman R.A. The cohort effect and Helicobacter pylori. J Infect Dis. 168:1993;219-221
22. Graham D.Y., Agrawal N.M., Roth S.H. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. II:1988;1277-1280
23. Graham D.Y., White R.H., Moreland L.W., Schubert T.T., Katz R., Jaszewski R., et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group. Ann Intern Med. 119:1993;257-262
24. Lau J.Y., Chung S.C., Leung J.W., Lo K.K., Yung M.Y., Li A.K. The evolution of stigmata of hemorrhage in bleeding peptic ulcers: a sequential endoscopic study. Endoscopy. 30:1998;513-518